474 related articles for article (PubMed ID: 21746896)
1. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.
Cheung HW; Cowley GS; Weir BA; Boehm JS; Rusin S; Scott JA; East A; Ali LD; Lizotte PH; Wong TC; Jiang G; Hsiao J; Mermel CH; Getz G; Barretina J; Gopal S; Tamayo P; Gould J; Tsherniak A; Stransky N; Luo B; Ren Y; Drapkin R; Bhatia SN; Mesirov JP; Garraway LA; Meyerson M; Lander ES; Root DE; Hahn WC
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12372-7. PubMed ID: 21746896
[TBL] [Abstract][Full Text] [Related]
2. A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells.
Di Palma T; Lucci V; de Cristofaro T; Filippone MG; Zannini M
BMC Cancer; 2014 Apr; 14():292. PubMed ID: 24766781
[TBL] [Abstract][Full Text] [Related]
3. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
4. A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities.
Vizeacoumar FJ; Arnold R; Vizeacoumar FS; Chandrashekhar M; Buzina A; Young JT; Kwan JH; Sayad A; Mero P; Lawo S; Tanaka H; Brown KR; Baryshnikova A; Mak AB; Fedyshyn Y; Wang Y; Brito GC; Kasimer D; Makhnevych T; Ketela T; Datti A; Babu M; Emili A; Pelletier L; Wrana J; Wainberg Z; Kim PM; Rottapel R; O'Brien CA; Andrews B; Boone C; Moffat J
Mol Syst Biol; 2013 Oct; 9():696. PubMed ID: 24104479
[TBL] [Abstract][Full Text] [Related]
5. PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.
Shi K; Yin X; Cai MC; Yan Y; Jia C; Ma P; Zhang S; Zhang Z; Gu Z; Zhang M; Di W; Zhuang G
Elife; 2019 May; 8():. PubMed ID: 31050342
[TBL] [Abstract][Full Text] [Related]
6. SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.
Lin L; Shi K; Zhou S; Cai MC; Zhang C; Sun Y; Zang J; Cheng L; Ye K; Ma P; Shen P; Zhang M; Cheng Y; Qi C; Li Y; Yin X; Zheng Y; Tan L; Zhuang G; Zang R
Oncogene; 2022 Mar; 41(12):1767-1779. PubMed ID: 35124696
[TBL] [Abstract][Full Text] [Related]
7. Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma.
Mhawech-Fauceglia P; Wang D; Samrao D; Godoy H; Ough F; Liu S; Pejovic T; Lele S
Gynecol Oncol; 2012 Oct; 127(1):198-201. PubMed ID: 22705448
[TBL] [Abstract][Full Text] [Related]
8. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
[TBL] [Abstract][Full Text] [Related]
9. Essential gene profiles in breast, pancreatic, and ovarian cancer cells.
Marcotte R; Brown KR; Suarez F; Sayad A; Karamboulas K; Krzyzanowski PM; Sircoulomb F; Medrano M; Fedyshyn Y; Koh JLY; van Dyk D; Fedyshyn B; Luhova M; Brito GC; Vizeacoumar FJ; Vizeacoumar FS; Datti A; Kasimer D; Buzina A; Mero P; Misquitta C; Normand J; Haider M; Ketela T; Wrana JL; Rottapel R; Neel BG; Moffat J
Cancer Discov; 2012 Feb; 2(2):172-189. PubMed ID: 22585861
[TBL] [Abstract][Full Text] [Related]
10. PAX8 expression in ovarian surface epithelial cells.
Adler E; Mhawech-Fauceglia P; Gayther SA; Lawrenson K
Hum Pathol; 2015 Jul; 46(7):948-56. PubMed ID: 26079312
[TBL] [Abstract][Full Text] [Related]
11. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
12. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancer.
Davis SJ; Sheppard KE; Pearson RB; Campbell IG; Gorringe KL; Simpson KJ
Clin Cancer Res; 2013 Mar; 19(6):1411-21. PubMed ID: 23362323
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
Hardy LR; Pergande MR; Esparza K; Heath KN; Önyüksel H; Cologna SM; Burdette JE
Oncogene; 2019 Aug; 38(32):6003-6016. PubMed ID: 31296958
[TBL] [Abstract][Full Text] [Related]
15. Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4.
Ren Y; Cheung HW; von Maltzhan G; Agrawal A; Cowley GS; Weir BA; Boehm JS; Tamayo P; Karst AM; Liu JF; Hirsch MS; Mesirov JP; Drapkin R; Root DE; Lo J; Fogal V; Ruoslahti E; Hahn WC; Bhatia SN
Sci Transl Med; 2012 Aug; 4(147):147ra112. PubMed ID: 22896676
[TBL] [Abstract][Full Text] [Related]
16. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.
Bowen NJ; Logani S; Dickerson EB; Kapa LB; Akhtar M; Benigno BB; McDonald JF
Gynecol Oncol; 2007 Feb; 104(2):331-7. PubMed ID: 17064757
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
Chien J; Fan JB; Bell DA; April C; Klotzle B; Ota T; Lingle WL; Gonzalez Bosquet J; Shridhar V; Hartmann LC
Gynecol Oncol; 2009 Jul; 114(1):3-11. PubMed ID: 19410283
[TBL] [Abstract][Full Text] [Related]
18. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.
Sethi G; Pathak HB; Zhang H; Zhou Y; Einarson MB; Vathipadiekal V; Gunewardena S; Birrer MJ; Godwin AK
PLoS One; 2012; 7(10):e47086. PubMed ID: 23056589
[TBL] [Abstract][Full Text] [Related]
19. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival.
Muratovska A; Zhou C; He S; Goodyer P; Eccles MR
Oncogene; 2003 Sep; 22(39):7989-97. PubMed ID: 12970747
[TBL] [Abstract][Full Text] [Related]
20. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
